Overview
Claire Vanpouille-Box, PhD, is an Assistant Professor in the Department of Radiation Oncology at Weill Cornell Medicine and Director of the Radiation Therapy Preclinical Core (RTPC).
Her research program investigates how radiation therapy influences tumor immunogenicity and how metabolic adaptation, particularly lipid metabolism, enables aggressive brain tumors to resist treatment and evade immune attack. She received her PhD from the University of Angers in France and completed postdoctoral training at NYU School of Medicine and Weill Cornell Medicine. Her work has helped define key mechanisms of radiation-induced anti-tumor immunity, including the role of TGF-β as a suppressor of immune responses and the importance of cancer cell-intrinsic type I interferon signaling in the abscopal effect.
She has been recognized with honors including the Marie Curie Award from the Radiation Research Society, the AACR–Susan G. Komen Scholar-in-Training Award, and the St. Baldrick’s Foundation Scholar Award.
She also serves in editorial roles for several journals in the field, including International Journal of Radiation Oncology - Biology - Physics, Radiation Research, and Journal of Translational Medicine.
Highlights
- 1Cancer letters · 2023
- 2Cancer letters · 2025
- 3Nature reviews. Immunology · 2024
Publications
Funding
Active
8 grants- KPTargeting fatty acid synthesis to restore anti-tumor immunity against irradiated glioblastomaPew Charitable Trusts · 2025–2029PCT 38590
- PIFatty acid metabolic regulation of anti-tumor immunity against irradiated glioblastomaNational Institute of Neurological Disorders and Stroke · 2023–2028R01NS131945-04
- Co-ICustomized nanofibers with preferential lung-targeting properties for treating metastatic pulmonary tumorsNational Cancer Institute · 2023–2027R37CA278671-01
- MPIDynamics of Immune Response in Irradiated Rectal CancerNational Cancer Institute · 2022–2027U54CA274291-01
- Co-IInvestigating PK modulation in targeted radiotherapyRatio Therapeutics, LLC · 2022–2026ContractSRA 224196-01
- PIRole of FAP-positive cells in immune response to irradiated glioblastomaNational Cancer Institute · 2023–2026R21CA280787-02
- PIRegulation of myeloid cells by fatty acid metabolism in irradiated glioblastomaUncle Kory Foundation · 2025–2025UKF 244480-01
- KPRole of CD36 in immune response to irradiated glioblastomaThe Brain Tumor Charity · 2023–2025BTC 224874-01
Completed grants (9)
- PIRegulation of myeloid cells by fatty acid metabolism in irradiated glioblastomaUncle Kory Foundation · 2024–2024UKF 234339-01
- PITargeting CAFs to sensitize irradiated pHGG to EGFR blockadeSt. Baldrick's Foundation · 2022–2024SBF 222633-02
- KPHypoxic incubator for physiological cell culture researchOffice of the Director, NIH · 2022–2023S10OD032317-01
- KPTargeting FASN to sensitize irradiated glioblastoma to immunotherapySociety For Immunotherapy of Cancer · 2022–2023SIC 224099-01
- PITargeting cancer-associated fibroblasts in irradiated pediatric brain tumorsStachestrong Inc. · 2022–2023SSI 224537-01
- PITargeting CAFs to sensitize irradiated glioblastoma to PD-1 blockade.Uncle Kory Foundation · 2021–2022UKF 221422-01
- KPCancer Cell Intrinsic Interferon-I Pathway Activation by Fractionated RadiationNational Cancer Institute · 2016–2022R01CA201246-05
- PIEvaluation of targeted alpha-radiation therapy to induce anti-tumor immune responses in mouse models of glioblastoma.B*CURED · 2019–2020BC 193359-01
- PIEvaluation of targeted alpha-radiation therapy to induce anti-tumor immune responses in a GL261 glioma model.Radiation Research Foundation · 2019–2020RRF 193737-01
Honors & distinctions
- Marie Curie Award · Radiation Research Society
- Member · Society for Immunotherapy of Cancer (SITC)
- Member · American Society for Radiation Oncology (ASTRO)
- Member · Radiation Research Society (RRS)
- Member · American Association for Cancer Research (AACR)
- St. Baldrick’s Foundation Scholar · St. Baldrick's Foundation
Available technologies
- FASN Inhibition Overcomes Radiation Resistance and Potentiates Anti-PD-1 Therapy in Glioblastoma11200Application filedPoC DataPMID 37499741